Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Mar;25(3):532-8.
doi: 10.1016/j.bbi.2010.12.003. Epub 2010 Dec 13.

Altered immunoglobulin profiles in children with Tourette syndrome

Netty G P Bos-Veneman  1 , Renske Olieman, Zuzana Tobiasova, Pieter J Hoekstra, Lily Katsovich, Alfred L M Bothwell, James F Leckman, Ivana Kawikova
Affiliations

Altered immunoglobulin profiles in children with Tourette syndrome

Netty G P Bos-Veneman et al. Brain Behav Immun. 2011 Mar.

Abstract

Background: Post-infectious autoimmunity and immune deficiency have been implicated in the pathogenesis of Tourette syndrome (TS). We asked here whether B cell immunity of patients with TS differs from healthy subjects.

Methods: In two independent cross-sectional samples, we compared serum levels of IgG1, IgG2, IgG3, IgG4, IgM, IgA, and IgE in 21 patients with TS from Yale University (17 males, 4 females, 8-16 years) versus 21 healthy controls (13 males, 8 females, 7-17 years); and in 53 patients with TS from Groningen University (45 males, 8 females, 6-18 years) versus 53 healthy controls (22 males, 31 females, 6-18 years), respectively. We also investigated correlations between Ig concentrations and symptom severity. In 13 additional patients (9 males, 4 females, age range 9-14), we established Ig profiles at time points before, during, and after symptom exacerbations.

Results: IgG3 levels were significantly lower in Yale patients compared to healthy children (medians 0.28 versus 0.49 mg/ml, p=.04), while levels of IgG2, IgG4, and IgM in patients were lower at trend-level significance (p≤.10). Decreased IgG3 (medians 0.45 versus 0.52 mg/ml; p=.05) and IgM (medians 0.30 versus 0.38 mg/ml; p=.04) levels were replicated in the Groningen patients. Ig levels did not correlate with symptom severity. There was a trend-level elevation of IgG1 during symptom exacerbations (p=.09).

Conclusion: These pilot data indicate that at least some patients with TS have decreased serum IgG3, and possibly also IgM levels, though only few subjects had fully expressed Ig immunodeficiency. Whether these changes are related to TS pathogenesis needs to be investigated.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Serum IgG3 levels in children with TS and healthy subjects of the Yale and Groningen samples. The bars represent the medians in each group.
Figure 2
Figure 2
Serum IgM levels in children with TS and healthy subjects of the Yale and Groningen samples. The bars represent the medians in each group.
Figure 3
Figure 3
Serum IgG1 levels of 13 children with TS before, during, and after an exacerbation of tics. Patients showed increased IgG1 levels during exacerbation: F(2, 24) = 2.63, p = .09.
See this image and copyright information in PMC

References

    1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4. Washington, DC: American Psychiatric Association; 2000. text revison (DSM-IV-TR)
    1. Baron-Cohen S, Scahill VL, Izaguirre J, Hornsey H, Robertson MM. The prevalence of Gilles de la Tourette syndrome in children and adolescents with autism: a large scale study. Psychol Med. 1999;29:1151–1159. - PubMed
    1. Boscarino JA. Posttraumatic stress disorder and physical illness: results from clinical and epidemiologic studies. Annals of the New York Academy of Sciences. 2004;1032:141–153. - PubMed
    1. Brynska A, Tomaszewicz-Libudzic E, Wolanczyk T. Obsessive-compulsive disorder and acquired toxoplasmosis in two children. European child & adolescent psychiatry. 2001;10:200–204. - PubMed
    1. Bussone G, Mouthon L. Autoimmune manifestations in primary immune deficiencies. Autoimmun Rev. 2009;8:332–336. - PubMed

Publication types

Substances